AIMC Topic: Mental Disorders

Clear Filters Showing 111 to 120 of 290 articles

Bridging the Skills Gap: Evaluating an AI-Assisted Provider Platform to Support Care Providers with Empathetic Delivery of Protocolized Therapy.

AMIA ... Annual Symposium proceedings. AMIA Symposium
Despite the high prevalence and burden of mental health conditions, there is a global shortage of mental health providers. Artificial Intelligence (AI) methods have been proposed as a way to address this shortage, by supporting providers with less ex...

Evaluation of deep learning-based depression detection using medical claims data.

Artificial intelligence in medicine
Human accuracy in diagnosing psychiatric disorders is still low. Even though digitizing health care leads to more and more data, the successful adoption of AI-based digital decision support (DDSS) is rare. One reason is that AI algorithms are often n...

Arts therapies for mental disorders in COVID-19 patients: a comprehensive review.

Frontiers in public health
BACKGROUND AND OBJECTIVE: The COVID-19 global pandemic has necessitated the urgency for innovative mental health interventions. We performed a comprehensive review of the available literature on the utility and efficacy of arts therapies in treating ...

Psychological factors underlying attitudes toward AI tools.

Nature human behaviour
What are the psychological factors driving attitudes toward artificial intelligence (AI) tools, and how can resistance to AI systems be overcome when they are beneficial? Here we first organize the main sources of resistance into five main categories...

Risk of data leakage in estimating the diagnostic performance of a deep-learning-based computer-aided system for psychiatric disorders.

Scientific reports
Deep-learning approaches with data augmentation have been widely used when developing neuroimaging-based computer-aided diagnosis (CAD) systems. To prevent the inflated diagnostic performance caused by data leakage, a correct cross-validation (CV) me...

Advancements in Drug Repurposing: Examples in Psychiatric Medications.

International journal of molecular sciences
Because there are a limited number of animal models for psychiatric diseases that can be extrapolated to humans, drug repurposing has been actively pursued. This study was aimed at uncovering recent trends in drug repurposing approaches and new techn...

New directions in psychiatric drug development: promising therapeutics in the pipeline.

Expert opinion on drug discovery
INTRODUCTION: Psychiatric disorders are a leading cause of disability worldwide, calling for an urgent need for new treatments, early detection, early intervention, and precision medicine. Drug discovery and development in psychiatry continues to exp...

Detecting individuals with severe mental illness using artificial intelligence applied to magnetic resonance imaging.

EBioMedicine
BACKGROUND: Identifying individuals at risk for severe mental illness (SMI) is crucial for prevention and early intervention strategies. While MRI shows potential for case identification even before illness onset, no practical model for mental health...